In this video, Michael J. Bloch, MD, discusses the use of combined oral contraceptives, which are the most common forms of birth control used by women in the United States, oral estrogen-free progestin-only...
Recently, therapy to reduce PCSK9 activity has been approved for use in those with cardiovascular disease who require additional LDL-C lowering despite the use of maximally tolerated statins.
In this video, Michael J. Bloch, MD, discusses the link between combined oral contraceptives and increased risk of arterial thrombosis, the risk of venous thromboembolic disease, and...
Previous reports have suggested that mean blood pressure (BP) increased during the early years of the COVID-19 pandemic across the United States.1 There have been many hypotheses regarding why–including...
In this video, Michael J. Bloch, MD, discusses hypertension and a patient-level pooled analysis of ultrasound renal denervation in the sham-controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO...
In this video, Michael Bloch, MD, provides a preview of the session “Opportunities to Improve Metabolic Syndrome With Your Patient” during our Practical Updates in Primary Care 2023 Virtual Series,...
In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
In this video, Michael Bloch, MD, provides a wrap-up of the session “Opportunities to Improve Metabolic Syndrome With Your Patient” during our Practical Updates in Primary Care 2023 Virtual Series,...
